Quantifying the impact of PFOA exposure on B-cell development and antibody production
Toxicological Sciences · 2023
DOI: 10.1093/toxsci/kfad043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2023. Verfasst von Krystal D Taylor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834-4300, USA. Hauptthemen laut MEDLINE: Alkanesulfonic Acids, Environmental Pollutants, Fluorocarbons. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences, NC State University Center for Environmental and Human Health Effects of PFAS.
Abstract (Originalsprache)
Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals; the vast majority are environmentally and biologically persistent, and some have demonstrated toxicity, including cancer, effects on metabolism, endocrine disruption, and immune dysfunction. Suppression of T-cell-dependent antibody responses (TDAR) has been observed in numerous studies of PFAS but mechanisms remain elusive. Evidence from our work suggests that B cells and how they use energy are impacted by PFAS exposure. We hypothesize that a well-studied and immunotoxic PFAS, perfluorooctanoic acid (PFOA), alters B-cell subclasses and markers of their metabolism. Adult male and female C57BL/6 mice were given PFOA (0 or 7.5 mg/kg) via gavage for 15 days, a duration and dose sufficient to suppress the TDAR. After dosing and immunization of subgroups, spleens were prepared to quantify B-cell subsets. Flow cytometric analysis revealed decreased numbers of plasmablasts, follicular, naïve, and overall B-cell subclasses in female PFOA-exposed groups. Male PFOA-exposed groups had a significant increase in follicular B cells and other subsets had decreases, including in the overall number of B cells. Twenty-four hours after naïve B-cell isolation and ex vivo activation, metabolic measurements revealed a 5-fold increase in metabolic markers in response to stimulation in PFOA-exposed groups compared with controls. These findings suggest that B-cell development and survival may be hindered by PFOA exposure, but that activation of the remaining B cells was not. Based on these findings, PFOA-mediated suppression of the primary IgM antibody response results changes to specific subsets of B cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834-4300, USA.
- Cytek Biosciences, Mid-Atlantic Region, Fremont, California 94538-6407, USA.
ORCID-Profile: Jamie C DeWitt
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- NC State University Center for Environmental and Human Health Effects of PFAS
- East Carolina University
- NC State University
Zitieren
APA
Taylor, K. D., Woodlief, T. L., Ahmed, A., Hu, Q., Duncker, P. C., & DeWitt, J. C. (2023). Quantifying the impact of PFOA exposure on B-cell development and antibody production. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfad043
Vancouver
Taylor KD, Woodlief TL, Ahmed A, Hu Q, Duncker PC, DeWitt JC. Quantifying the impact of PFOA exposure on B-cell development and antibody production. Toxicological Sciences. 2023. doi:10.1093/toxsci/kfad043
BibTeX
@article{Taylor2023,
author = {Taylor, Krystal D and Woodlief, Tracey L and Ahmed, Aya and Hu, Qing and Duncker, Patrick C and DeWitt, Jamie C},
title = {Quantifying the impact of PFOA exposure on B-cell development and antibody production},
journal = {Toxicological Sciences},
year = {2023},
doi = {10.1093/toxsci/kfad043}
}
EUVIMED